Friday 6 November 2026 Export TXG’s income statement to Excel — free account

10x Genomics

TXG Healthcare Medical Devices

10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024.

Revenue: +1.12%
EPS: +31.8%
Free cash flow: −4.61%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

58.35 0.29 +0.50%

Follow TXG

Alert me

Market cap: $7.6B
P/E: 0.0×
Fwd P/E: −95.9×
Dividend yield: —
F-score: 6/9
Altman Z: 3.99
Beneish M: −3.23
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

10x Genomics (TXG) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, 10x Genomics (TXG) trades at a P/B ratio of 9.2×. Over the past ten years it has ranged from 0.0× (December 2019) to 31.6× (September 2020); the current reading is higher than 65% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TXG/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="10x Genomics P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TXG/metrics/pb-ratio">10x Genomics (TXG) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	2.6×	4.90%
FY2024	2.4×	(71.63%)
FY2023	8.6×	71.97%
FY2022	5.0×	(75.17%)
FY2021	20.1×	3.74%
FY2020	19.4×	11.19%
FY2019	17.4×	—
FY2018	0.0×	—
FY2017	0.0×	—

Period	P/B ratio	Change
Sep 2026	14.1×	133.64%
Jun 2026	6.0×	80.49%
Mar 2026	3.3×	30.90%
Dec 2025	2.6×	36.73%
27 more quarters	Free account

Against its own ten years

Low 0.0× High 31.6×

Ten-year median 6.8×

Current reading's percentile 64

Company	P/B ratio
BIO Bio-Rad Laboratories, Inc. compare	1.3×
BIO.B Bio-Rad Laboratories, Inc. compare	1.3×
GMED Globus Medical, Inc. compare	2.3×
SNN Smith & Nephew SNATS, Inc. compare	2.8×
BRKR Bruker Corporation compare	3.7×
HAE Haemonetics Corporation compare	6.2×
PODD Insulet Corporation compare	7.6×
PEN Penumbra, Inc. compare	8.0×
TXG 10x Genomics	9.2×
Medical Devices industry median	2.5×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

10x Genomics (TXG) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on TXG

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on TXG

Stockrow Weekly